These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 19591797)
1. Overcoming innate host resistance to vaccination: employing a genetically distinct strain of murine cytomegalovirus avoids vector-mediated resistance to virally vectored immunocontraception. Nikolovski S; Lloyd ML; Harvey N; Hardy CM; Shellam GR; Redwood AJ Vaccine; 2009 Aug; 27(38):5226-32. PubMed ID: 19591797 [TBL] [Abstract][Full Text] [Related]
2. Prior infection with murine cytomegalovirus (MCMV) limits the immunocontraceptive effects of an MCMV vector expressing the mouse zona-pellucida-3 protein. Gorman S; Lloyd ML; Smith LM; McWhorter AR; Lawson MA; Redwood AJ; Shellam GR Vaccine; 2008 Jul; 26(31):3860-9. PubMed ID: 18573574 [TBL] [Abstract][Full Text] [Related]
3. Promoter control over foreign antigen expression in a murine cytomegalovirus vaccine vector. Cunningham PT; Lloyd ML; Harvey NL; Williams E; Hardy CM; Redwood AJ; Lawson MA; Shellam GR Vaccine; 2010 Dec; 29(1):141-51. PubMed ID: 20338212 [TBL] [Abstract][Full Text] [Related]
4. Viral vectored immunocontraception: screening of multiple fertility antigens using murine cytomegalovirus as a vaccine vector. Redwood AJ; Harvey NL; Lloyd M; Lawson MA; Hardy CM; Shellam GR Vaccine; 2007 Jan; 25(4):698-708. PubMed ID: 17070624 [TBL] [Abstract][Full Text] [Related]
5. Use of a murine cytomegalovirus K181-derived bacterial artificial chromosome as a vaccine vector for immunocontraception. Redwood AJ; Messerle M; Harvey NL; Hardy CM; Koszinowski UH; Lawson MA; Shellam GR J Virol; 2005 Mar; 79(5):2998-3008. PubMed ID: 15709020 [TBL] [Abstract][Full Text] [Related]
6. Species-specificity of a murine immunocontraceptive utilising murine cytomegalovirus as a gene delivery vector. Smith LM; Lloyd ML; Harvey NL; Redwood AJ; Lawson MA; Shellam GR Vaccine; 2005 Apr; 23(23):2959-69. PubMed ID: 15811641 [TBL] [Abstract][Full Text] [Related]
7. Immunization with recombinant murine cytomegalovirus expressing murine zona pellucida 3 causes permanent infertility in BALB/c mice due to follicle depletion and ovulation failure. O'Leary S; Lloyd ML; Shellam GR; Robertson SA Biol Reprod; 2008 Nov; 79(5):849-60. PubMed ID: 18667753 [TBL] [Abstract][Full Text] [Related]
8. Innate antiviral resistance influences the efficacy of a recombinant murine cytomegalovirus immunocontraceptive vaccine. Lloyd ML; Nikolovski S; Lawson MA; Shellam GR Vaccine; 2007 Jan; 25(4):679-90. PubMed ID: 17007971 [TBL] [Abstract][Full Text] [Related]
9. Current status of virally vectored immunocontraception for biological control of mice. Hardy CM Soc Reprod Fertil Suppl; 2007; 63():495-506. PubMed ID: 17566294 [TBL] [Abstract][Full Text] [Related]
10. Ly49h-deficient C57BL/6 mice: a new mouse cytomegalovirus-susceptible model remains resistant to unrelated pathogens controlled by the NK gene complex. Fodil-Cornu N; Lee SH; Belanger S; Makrigiannis AP; Biron CA; Buller RM; Vidal SM J Immunol; 2008 Nov; 181(9):6394-405. PubMed ID: 18941230 [TBL] [Abstract][Full Text] [Related]
11. Cmv1-independent antiviral role of NK cells revealed in murine cytomegalovirus-infected New Zealand White mice. Rodriguez M; Sabastian P; Clark P; Brown MG J Immunol; 2004 Nov; 173(10):6312-8. PubMed ID: 15528370 [TBL] [Abstract][Full Text] [Related]
12. Functional consequences of natural sequence variation of murine cytomegalovirus m157 for Ly49 receptor specificity and NK cell activation. Corbett AJ; Coudert JD; Forbes CA; Scalzo AA J Immunol; 2011 Feb; 186(3):1713-22. PubMed ID: 21187440 [TBL] [Abstract][Full Text] [Related]
13. Gain of virulence caused by loss of a gene in murine cytomegalovirus. Bubić I; Wagner M; Krmpotić A; Saulig T; Kim S; Yokoyama WM; Jonjić S; Koszinowski UH J Virol; 2004 Jul; 78(14):7536-44. PubMed ID: 15220428 [TBL] [Abstract][Full Text] [Related]
14. The effects of GM-CSF and IL-5 as molecular adjuvants on immune responses and contraception induced by mZP3 DNA vaccination. Ma X; Kadir Z; Li J; Zhang F Am J Reprod Immunol; 2012 Dec; 68(6):476-85. PubMed ID: 22934542 [TBL] [Abstract][Full Text] [Related]
15. Natural killer cells attenuate cytomegalovirus-induced hearing loss in mice. Almishaal AA; Mathur PD; Hillas E; Chen L; Zhang A; Yang J; Wang Y; Yokoyama WM; Firpo MA; Park AH PLoS Pathog; 2017 Aug; 13(8):e1006599. PubMed ID: 28859161 [TBL] [Abstract][Full Text] [Related]
16. Distinct MHC class I-dependent NK cell-activating receptors control cytomegalovirus infection in different mouse strains. Pyzik M; Charbonneau B; Gendron-Pontbriand EM; Babić M; Krmpotić A; Jonjić S; Vidal SM J Exp Med; 2011 May; 208(5):1105-17. PubMed ID: 21518798 [TBL] [Abstract][Full Text] [Related]
17. Contraceptive responses of mice immunized with purified recombinant mouse zona pellucida subunit 3 (mZP3) proteins. Hardy CM; ten Have JF; Pekin J; Beaton S; Jackson RJ; Clydesdale G Reproduction; 2003 Jul; 126(1):49-59. PubMed ID: 12814347 [TBL] [Abstract][Full Text] [Related]
18. Intranasal co-delivery with the mouse zona pellucida 3 and GM-CSF expressing constructs enhances humoral immune responses and contraception in mice. Ma X; Li J; Zhang F Scand J Immunol; 2012 Dec; 76(6):521-7. PubMed ID: 22924630 [TBL] [Abstract][Full Text] [Related]
19. Characterization of murine cytomegalovirus m157 from infected cells and identification of critical residues mediating recognition by the NK cell receptor Ly49H. Davis AH; Guseva NV; Ball BL; Heusel JW J Immunol; 2008 Jul; 181(1):265-75. PubMed ID: 18566392 [TBL] [Abstract][Full Text] [Related]
20. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Arase H; Mocarski ES; Campbell AE; Hill AB; Lanier LL Science; 2002 May; 296(5571):1323-6. PubMed ID: 11950999 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]